Coronary No-reflow Phenomenon

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• No-reflow phenomenon affects up to one-third of patients undergoing percutaneous coronary intervention for acute myocardial infarction.
• It can also occur during elective procedures, especially in vein graft interventions.

Purpose of the Study:

• To review strategies for managing the no-reflow phenomenon during percutaneous coronary interventions.
• To highlight the importance of restoring coronary flow for myocardial function and patient prognosis.

Main Methods:

• Administration of intracoronary medications including nitroprusside, verapamil, or adenosine.
• Distal injection via an intracoronary perfusion catheter to minimize systemic effects.
• Prophylactic injections may be used, particularly in vein graft interventions.

Main Results:

• Multiple intracoronary medications can restore flow in the majority of no-reflow cases.
• Dosages range from 100 to 1000 mg, administered in 100-mg increments at high velocity.

Conclusions:

• While not formally approved, intracoronary medication strategies are essential for treating no-reflow.
• Reversing no-reflow is critical for improving left ventricular function and overall cardiac outcomes.